top 53 has been researched along with methyl methanesulfonate in 1 studies
*Methyl Methanesulfonate: An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. [MeSH]
*Methyl Methanesulfonate: An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. [MeSH]
Studies (top 53) | Trials (top 53) | Recent Studies (post-2010) (top 53) | Studies (methyl methanesulfonate) | Trials (methyl methanesulfonate) | Recent Studies (post-2010) (methyl methanesulfonate) |
---|---|---|---|---|---|
7 | 0 | 0 | 2,461 | 0 | 394 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, AM; Hartsuiker, E; Neale, MJ | 1 |
1 other study(ies) available for top 53 and methyl methanesulfonate
Article | Year |
---|---|
Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA.
Topics: Camptothecin; Cell Nucleolus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Fungal; Etoposide; Exodeoxyribonucleases; Gamma Rays; Methyl Methanesulfonate; Mutant Proteins; Mutation; Protein Binding; Schizosaccharomyces; Schizosaccharomyces pombe Proteins | 2009 |